Publication:
Cyclosporine

dc.contributor.authorONSUN, Nahide
dc.contributor.institutionauthorONSUN, NAHIDE
dc.date.accessioned2022-09-13T20:59:19Z
dc.date.available2022-09-13T20:59:19Z
dc.date.issued2022-01-01T00:00:00Z
dc.description.abstractCyclosporine is an immunosuppressive agent used in the treatment of psoriasis. It shows its action through calcineurin inhibition and T-lymphocytes. With its rapid effect, it can be used as an induction therapy in plaque, pustular and erythrodermic psoriasis. Its most common side effects are elevated serum creatinin values and arterial hypertension. In long-term treatment not to exceed 2 years, it may be used under nephrology control.
dc.identifier.citationONSUN N., -Cyclosporine-, TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, cilt.56, ss.26-28, 2022
dc.identifier.doi10.4274/turkderm.galenos.2022.78910
dc.identifier.urihttp://hdl.handle.net/20.500.12645/30984
dc.identifier.wosWOS:000840123800007
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleCyclosporine
dc.typeArticle
dspace.entity.typePublication
local.avesis.idc9d4cb80-db9d-4d20-8ca7-f90a4ba398a7
local.indexed.atWOS
local.publication.isinternational1
relation.isAuthorOfPublication1ebc9a95-ecf2-4c81-9f74-3c5fb32a9406
relation.isAuthorOfPublication.latestForDiscovery1ebc9a95-ecf2-4c81-9f74-3c5fb32a9406

Files